We are live on ! Find out more
TELA icon

TELA Bio
TELA

22 hedge funds and large institutions have $82.7M invested in TELA Bio in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55.95% more ownership

Funds ownership: 0% → 55.95% (+56%)

Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$37M
2
RI
RTW Investments
New York
+$13.9M
3
EWM
Essex Woodlands Management
Texas
+$9.41M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$4.89M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$2.46M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$39.2M +$37M +3,027,542 New
RI
2
RTW Investments
New York
$14.8M +$13.9M +1,139,358 New
EWM
3
Essex Woodlands Management
Texas
$9.96M +$9.41M +769,231 New
Federated Hermes
4
Federated Hermes
Pennsylvania
$5.18M +$4.89M +400,000 New
WP
5
Woodline Partners
California
$2.96M +$2.79M +228,534 New
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$2.61M +$2.46M +201,471 New
OM
7
Opaleye Management
Massachusetts
$2.27M +$2.14M +175,000 New
SSA
8
Schonfeld Strategic Advisors
New York
$1.42M +$1.34M +109,600 New
Millennium Management
9
Millennium Management
New York
$705K +$666K +54,423 New
PCM
10
Pentwater Capital Management
Florida
$689K +$651K +53,239 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$647K +$611K +50,000 New
Wellington Management Group
12
Wellington Management Group
Massachusetts
$355K +$336K +27,471 New
PHP
13
Parkman Healthcare Partners
Connecticut
$324K +$306K +25,000 New
CAC
14
Cowen and Company
New York
$309K +$291K +23,831 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$303K +$287K +23,429 New
UBS Group
16
UBS Group
Switzerland
$210K +$198K +16,181 New
Two Sigma Investments
17
Two Sigma Investments
New York
$154K +$145K +11,886 New
CS
18
Credit Suisse
Switzerland
$141K +$133K +10,900 New
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$141K +$133K +10,900 New
Northern Trust
20
Northern Trust
Illinois
$134K +$127K +10,348 New
PCM
21
Perkins Capital Management
Minnesota
$130K +$122K +10,000 New
BlackRock
22
BlackRock
New York
$77K +$72K +5,889 New

TELA Hedge Fund Activity: Q4 2019 in Review

22 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q4 2019, worth a combined $82.7M.

Buyers outnumbered sellers: 22 funds opened new TELA positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $37M.

  • 22 institutional investors held TELA Bio (TELA) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $82.7M of TELA Bio stock for Q4 2019.
  • 22 funds opened new TELA Bio positions in Q4 2019 and 0 closed out, a net change of +22 holders.
  • The largest TELA Bio buyer in Q4 2019 was OrbiMed, an estimated $37M added.

Based on aggregated 13F filings for Q4 2019.